Health Canada

Health Canada’s commitments for an accessible and barrier-free Canada.

This report, which is tabled under section 20 of the Service Fees Act and section 4.2.8 of the Directive on Charging and Special Financial Authorities, contains information about the fees that Health Canada had the authority to charge in the 2022-23 fiscal year.

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.

This report, which is tabled under section 20 of the Service Fees Act and section 4.2.8 of the Directive on Charging and Special Financial Authorities, contains information about the fees that Health Canada had the authority to charge in the 2021-22 fiscal year.

The organizational security plan (OSP) captures the risk mitigation measures that are in place to prevent, identify and respond to potential incidents that could result in the diversion of cannabis to or from the illicit market.

Briefing packages prepared for the purpose of enabling a new Minister or Deputy Minister to assume their new responsibilities, Overview of the Health Portfolio and its five organizations, Covid overview, First 100 days, Pocket book with Health Portfolio highlights,

This report, which is tabled under section 20 of the Service Fees Act and section 4.2.8 of the Directive on Charging and Special Financial Authorities, contains information about the fees that Health Canada had the authority to charge in the 2020-21 fiscal year.

Briefing packages for President, Minister and Deputy Ministers’ Parliamentary Committee appearances. President of the PHAC before the Standing Committee on Health: Canadian Response to the Novel Coronavirus (January 29, 2020)

Briefing packages for President, Minister and Deputy Ministers’ Parliamentary Committee appearances.

Briefing packages for Minister and Deputy Ministers’ Parliamentary Committee appearances. Appearance of the Deputy Minister of Health before the Standing Committee on Health on Coronavirus

Appearance of the Deputy Minister of Health before the Standing Committee on Health on Coronavirus

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the...

"Health Canada appreciates the critical role health professionals in Canada play in identifying, reporting and managing potential cases of COVID-19 and recognizes the pressures a surge in people requiring medical care can cause on facilities. In light of the current situation, Health Canada is...

In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.